Reason for Erratum:

Due to a typesetting error, the article was published with incorrect values in Table [4](#T1){ref-type="table"}. The publisher apologizes for this error and the correct version of Table [4](#T1){ref-type="table"} appears below. This error does not change the scientific conclusions of the article in any way.

###### 

**MM-PBSA results compared to experimental binding parameters**.

  **Complex**             **Binding parameters**   **MM-PBSA energy terms (KJ/mol)**                                                              
  ----------------------- ------------------------ ----------------------------------- ------ ------------ ----------- ------------- ------------ -----------
  Ranibizumab/VEGFA       1.60                     0.73                                46     −760 ± 40    −418 ± 5    −160 ± 20     410 ± 30     −592 ± 7
  Fab-bevacizumab/VEGFA   5.30                     3.10                                58     −807 ± 30    −362 ± 10   −252 ± 20     343 ± 30     −536 ± 7
  VEGFR1d2_R2d3/VEGFA     410                      2.01                                0.49   −1440 ± 90   −307 ± 50   −1433 ± 100   1050 ± 100   −750 ± 40

Kinetic and binding parameters are from Papadopoulos et al. ([@B1]).
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